Mutations in microRNA-128-2-3p identified with amplification-free hybridization assay

PLoS One. 2023 Aug 22;18(8):e0289556. doi: 10.1371/journal.pone.0289556. eCollection 2023.

Abstract

We describe a quantitative detection method for mutated microRNA in human plasma samples. Specific oligonucleotides designed from a Peyrard-Bishop model allowed accurate prediction of target:probe recognition affinity and specificity. Our amplification-free tandem bead-based hybridization assay had limit of detection of 2.2 pM. Thereby, the assay allowed identification of single-nucleotide polymorphism mismatch profiles in clinically relevant microRNA-128-2-3p, showing terminal mutations that correlate positively with inflammatory colitis and colorectal cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Assay
  • Humans
  • Hybridization, Genetic*
  • MicroRNAs* / genetics
  • Mutation
  • Nucleic Acid Hybridization

Substances

  • MicroRNAs
  • MIRN128 microRNA, human

Grants and funding

This study was financially supported by DTU Enable in the form of a grant (40996) awarded to KA. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.